Skip to content
Calculadora Capital
MRKStocksNYSEUSD

Merck (MRK) stock: return calculator

Merck & Co. (MRK) shares, one of the world's largest pharmaceutical companies, listed in New York.

US$149.50Latest price · 21 Sept 2026 close

Updated

Type
Stocks
Market
NYSE
Currency
USD
Sector
Healthcare
Data range
2016-07 – 2026-09 · 10 years
Source
Yahoo Finance

US$1,000 invested 10 years ago would be worth today

US$3,412

+241.2% total return

Try your own values in the calculators below.

Return calculator

Pick an amount and a period to see what an investment in Merck (MRK) would be worth today. By default we include reinvested dividends (total return).

Lump sum

What a one-off investment would be worth today.

Value today
US$3,412
Total return
+241.2%
Annualised return
+13.1%

Monthly investing (DCA)

What investing the same amount every month would be worth.

Value today
US$26,640
Profit
US$14,540
Total invested
US$12,100

Estimate before taxes, fees and currency-conversion costs. Past performance does not guarantee future returns.

Investment growth

US$1,000US$3,630
Growth of US$1,000 invested, 2016-07 to 2026-09.

Performance

Annualised return
+13.5%
Best year (2022)
+50%
Worst year (2020)
-7%
Largest drop
-39.7%

Data for the last 10 years · 2016-072026-09

Comparison with the market

US$1,000 invested vs S&P 500 ETF (SPY):

Merck (MRK)
US$3,630
S&P 500 ETF (SPY)
US$3,999

Merck (MRK) trailed S&P 500 ETF (SPY) over this period.

Risk & drawdowns

The largest peak-to-trough drop in the window was -39.7%. An investor who bought near the prior peak would have seen the investment fall significantly before recovering.

Scenarios

Illustrative results based on the available data.

  • US$1,000 5 years ago

    US$2,326

    lump sum, +132.6% return

  • US$100/mo for 5 years

    US$9,836

    invested US$6,100

  • If it repeats +13.5%/yr for 10 years

    US$3,554

    projection from US$1,000 (hypothetical)

About Merck (MRK)

Merck & Co. is one of the largest pharmaceutical companies in the world. Its most important medicine is Keytruda, a cancer immunotherapy that is now one of the best-selling drugs on the planet and accounts for a huge share of revenue. It also has a strong vaccines business (such as Gardasil) and an animal-health division.

It trades on the New York Stock Exchange (NYSE) under the ticker MRK and is part of the S&P 500 and Dow Jones indices. It is a defensive, dividend-paying stock. An important distinction: in the United States and Canada it is called Merck & Co., but in the rest of the world it operates as MSD, because there the "Merck" name belongs to the German pharmaceutical company Merck KGaA, a different business.

Related calculators

Other assets

Frequently asked questions

How much did Merck (MRK) stock return over the last 10 years?
+263% in total, or about +13.5% per year, on a total-return basis (dividends reinvested), between 2016-07 and 2026-09.
Do these calculations include dividends?
By default yes (total return). Turn off "include dividends" to see price-only appreciation.
Do they include taxes or fees?
No. These are estimates before taxes, broker fees and currency-conversion costs.
What currency are the values in?
USD. A euro-based investor also carries EUR/USD currency risk, not reflected here.
Does past performance predict the future?
No. Past performance does not guarantee future returns; this is educational information, not advice.

Sources & methodology

Prices: Yahoo Finance. Monthly series, total return (dividends reinvested). Data through 2026-09-21.

Total return assumes dividends are reinvested; you can turn that off to see price-only appreciation. Values are estimates before taxes, fees and currency-conversion costs.

Page generated and reviewed by the Calculadora Capital editorial team. Last updated 2026-09-21.